Inflammatory/stress feedback dysregulation in women with fibromyalgia

NeuroImmunoModulation

Volumn 19, Issue 6, 2012, Pages 343-351

  Bote, Maria E ^a   Garca, Juan J ^a   Hinchado, Maria D ^a   Ortega, Eduardo ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Cortisol; CRP IL 18; Hsp72; IL 8; Monocyte chemotactic protein 1; Monocytes; Neutrophils; Noradrenaline; RANTES

Indexed keywords

C REACTIVE PROTEIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HEAT SHOCK PROTEIN 27; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NORADRENALIN; RANTES; SEROTONIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROMYALGIA; FUNGICIDAL ACTIVITY; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; MONOCYTE; NEUROENDOCRINE SYSTEM; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STRESS;

ADULT; CHEMOTAXIS, LEUKOCYTE; FEEDBACK, PHYSIOLOGICAL; FEMALE; FIBROMYALGIA; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; OXIDATIVE STRESS; PHAGOCYTOSIS;

EID: 84866172543     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000341664     Document Type: Article

References (43)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al.: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-172.
2. Van West D, Maes M: Neuroendocrine and immune aspects of fibromyalgia. BioDrugs 2001; 15: 521-531.
3. Müller W, Schneider EM, Stratz T: The classification of fibromyalgia syndrome. Rheumatol Int 2007; 27: 1005-1010.
4. Giesecke T, Williams DA, Harris RE, Cupps TR, Tian TX, Gracely RH, Clauw DJ: Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 2003; 48: 2916-2922.
5. Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH: Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumathology 2001; 40: 743-749.
6. Gür A, Karakoç M, Nas K, Cevik R, Denli A, Saraç J: Cytokines and depression in cases with fibromylagia. J Rheumatol 2002; 29: 358-361.
7. Wang H, Moser M, Schiltenwolf M, Buchner M: Circulating cytokine levels compared to pain in patients with fibromyalgia: a prospective longitudinal study over 6 months. J Rheumatol 2008; 35: 1366-1370.
8. Ortega E, García JJ, Bote ME, Martín-Cordero L, Escalante Y, Saavedra JM, Northoff H, Giraldo E: Exercise in fibromialgia and related inflammatory disorders: known effects and unknown chances. Exerc Immunol Rev 2009; 15: 42-65.
9. Ortega E, Bote E, Giraldo E, García JJ: Aquatic exercise improves the monocyte pro-and anti-inflammatory cytokine production balance in fibromyalgia patients. Scand J Med Sci Sports 2012; 22: 104-112.
10. Ortega E: Why exercise can improve the symptoms of fibromyalgia? (in Spanish.) Med Clin 2011; 137: 405-407.
11. Ortega E, Forner MA, Barriga C: Exerciseinduced stimulation of murine macrophage chemotaxis: role of corticosterone and prolactin as mediators. J Physiol 1997; 498: 729-734.
12. Boyden S: The chemotaxis effect of mixtures of antibody and antigen on polymorphonuclear leukocyte. J Exp Med 1962; 115: 453-456.
13. Ortega E, Collazos ME, Maynar M, Barriga C: Stimulation of the phagocytic function of neutrophils in sedentary men alters acute moderate exercise. Eur J Appl Physiol Occup Physiol 1993; 66: 60-64.
14. Giraldo E, Martín-Cordero L, García JJ, Gerhmann M, Multhoff G, Ortega E: Exercise-induced extracellular 72 kDa heat shock protein (Hsp72) stimulates neutrophil phagocytic and fungicidal capacities via TLR-2. Eur J Appl Physiol 2010; 108: 217-225.
15. García JJ, Bote E, Hinchado MD, Ortega E: A single session of intense exercise improves the inflammatory response in healthy sedentary women. Physiol Biochem 2011; 67: 87-94.
16. Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH. Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 1991; 104: 765-767.
17. Bazzichi L, Rossi A, Massimetti G, Giannaccini G, Giuliano T, De Feo F, Ciapparelli A, Dell'Osso L, Bombardieri S: Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 2007; 25: 225-230.
18. Gür A, Oktayoglu P: Status of immune mediators in fibromyalgia. Curr Pain Headache Rep 2008; 12: 175-181.
19. Crofford LJ, Young EA, Engleberg NC, Korszum A, Brucksch CB, McClure LA, Brown MB, Demitrack MA: Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun 2004; 18: 314-325.
20. Geiss A, Rohleder N, Anton F: Evidence for an association between an enhanced reactivity of interleukin-6 and reduced glucocorticoid sensitivity in patients with fibromyalgia. Psychoneuroendocrinology 2012; 37: 671-684.
21. Lindquist S, Craig EA: The heat-shock proteins. Annu Rev Genet 1988; 22: 631-677.
22. Ortega E, Hinchado MD, Martín-Cordero L, Asea A: The effect of stress-inducible extracllular Hsp72 on human neutrophil chemotaxis: a role during acute intense exercise. Stress 2009; 12: 240-249.
23. Fleshner M, Campisi J, Amiri L, Diamond DM: Cat exposure induces both intra-and extracellular Hsp72: the role of adrenal hormones. Psychoneuroendocrinology 2004; 29: 1142-1152.
24. Campisi J, Leem TM, Fleshner M: Stress-induced extracellular Hsp72 is a functionally significant danger signal to the immune system. Cell Stress Chaperones 2003; 8: 272-286.
25. Giraldo E, Multhoff G, Ortega E: Noradrenaline increases the expression and release of Hsp72 by human neutrophils. Brain Behav Immun 2010; 24: 672-677.
26. Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J: Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 1997; 24: 555-559.
27. Ernberg M, Lundeberg T, Kopp S: Effects on muscle pain by intramuscular injection of granisetron in patients with fibromyalgia. Pain 2003; 101: 275-282.
28. Di Franco M, Iannuccelli C, Atzeni F, Cazzola M, Salaffi F, Valesini G, Sarzi-Puttini: Pharmacological treatment of fibromyalgia. Clin Exp Rheumatol 2010; 28: 110-116.
29. Bennett RM, Clark SC, Walczyk J: A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 1998; 104: 227-231.
30. McCall-Hosenfeld JS, Goldenberg DL, Hurwitz S, Adler GK: Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia. J Rheumatol 2003; 30: 809-814.
31. Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM: Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. J Rheumatol 1997; 24: 1384-1389.
32. Cuatrecasas G, Riudavets C, Güell MA, Na-dal A: Growth hormone as concomitant treatment in severe fibromialgia associated with low IGF-1 serum levels: a pilot study. BMC Musculoskelet Disord 2007; 8:119.
33. Dinarello CA, Novick D, Puren AJ, Fantuzzi G, Shapiro L, Mühl H, Yoon DY, Reznikov LL, Kim SH, Rubinstein M: Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol 1998; 63: 658-664.
34. Kohno K, Kurimoto M: Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clin Immunol Immunopathol 1998; 86: 11-15.
35. Ferreira AM, Rollins BJ, Faunce DE, Burns AL, Zhu X, Dipietro LA: The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network in acute inflammation. Cytokine 2005; 30: 64-71.
36. Zhang Z, Cherryholmes G, Mao A, Marek C, Longmate J, Kalos M, Amand, RP, Shively JE: High plasma levels of MPC-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med 2008; 233: 1171-1180.
37. Blanco I, Janciauskiene S, Nita I, Fernández-Bustillo E, Cárcaba V, Gallo C, Álvarez-Rico M, de Serres F, Béridze N: Low plasma levels of monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-alpha (TNFalpha), and vascular endotelial growth factor (VEGF) in patients with alpha1-antitrypsin deficiency-related fibromyalgia. Clin Rheumatol 2010; 29: 189-197.
38. Giraldo E, Hinchado MD, García JJ, Ortega E: Influence of gender and oral contraceptives intake on innate and inflammatory response: role of neuroendocrine factors. Mol Cell Biochem 2008; 313: 147-153.
39. Garrison RL, Breeding PC: A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Med Hypotheses 2003; 61: 182-189.
40. Ortega E, Giraldo E, Hinchado MD, Martinez M, Ibáñez S, Cidoncha A, Collazos ME, García JJ: Role of Hsp72 and norepinephine in the moderate exercise-induced stimulation of neutrophils' microbicide capacity. Eur J Appl Physiol 2006; 98: 250-255.
41. Ortega E, Giraldo E, Hinchado MD, Marín L, García JJ, De la Fuente M: Neuroinmmunomodulation during exercise: role of catecholamines as 'stress mediator' and/or 'danger signal' for the innate immune response. Neuroinmmunomodulation 2007; 98: 250-255.
42. Ortega E, Giraldo E, Hinchado MD, Martín-Cordero L, García JJ: 72 kDa extracellular heat shock protein (eHsp72), norepinephrine (NE), and the innate immune response following moderate exercise; in Asea A, Pedersen BK (eds): Heat Shock Proteins and Whole Body Physiology. New York, Springer, 2010, pp 329-350.
43. Kaufmann I, Schelling G, Eisner C, Richter HP, Krauseneck T, Vogeser M, Hauer D, Campolongo P, Chouker A, Beyer A, Thiel M: Anandamide and neutrophils function in patients with fibromyalgia. Psychoneuroendocrinology 2008; 33: 676-685.